IQVIA & Veeva Announce Global Clinical & Commercial Partnerships

IQVIA & Veeva Announce Global Clinical & Commercial Partnerships

The agreement allows customers to use both companies’ software, data, technology, and services in an integrated and efficient manner.

IQVIA and Veeva Systems have finalized long-term global clinical and commercial partnerships and resolved all pending legal disputes.

The agreement allows customers to use both companies’ software, data, technology, and services in an integrated and efficient manner.

On the commercial side, master data and software third-party access agreements now enable IQVIA and Veeva data to be used with each other’s software. This includes IQVIA data in Veeva Network for master data management (MDM), Veeva Nitro for analytics, and Veeva AI. Similarly, Veeva data can be leveraged in IQVIA commercial products. IQVIA has joined the Veeva Technology, AI, and Services Partner Programs to support seamless customer integrations across IQVIA Analytics, IQVIA Information Management (including MDM), IQVIA Agentic AI, and IQVIA Commercial Orchestration offerings.

Ari Bousbib, chairman and CEO of IQVIA, added, “IQVIA and Veeva’s partnerships bring together best-in-class capabilities in information, AI, technology, and services for our shared clients. This will enable IQVIA customers on Veeva platforms to accelerate clinical development, bring treatments to market more efficiently, and improve patient access to innovations.”

Additionally, IQVIA joins Veeva’s CRO Clinical Data Partner program in clinical operations. It uses the Veeva Clinical Suite to execute trials, including study builds with Veeva EDC. Customers can leverage IQVIA’s expertise in clinical data management, technology solutions, and EDC programming to accelerate database builds, study locks, and data delivery.

Veeva founder and CEO Peter Gassner said, “We are committed to supporting frictionless product and services integration with IQVIA to benefit our joint customers and the industry overall. I am excited about the potential for our clinical and commercial partnerships to create significant value for our shared customers.”

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All

Sign In / Sign up